{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T11:07:16Z","timestamp":1746788836266},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","labmed.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.cll.2016.07.007","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T01:07:56Z","timestamp":1476752876000},"page":"673-684","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Toxicology in Pain Management"],"prefix":"10.1016","volume":"36","author":[{"given":"Daniel A.","family":"Schwarz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin H.","family":"Bluth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cll.2016.07.007_bib1","first-page":"123","article-title":"Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?","volume":"9","author":"Manchikanti","year":"2006","journal-title":"Pain Physician"},{"issue":"2","key":"10.1016\/j.cll.2016.07.007_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.36076\/ppj.2011\/14\/189","article-title":"Illicit drug use in the pain patient population decreases with continued drug testing","volume":"14","author":"Pesce","year":"2011","journal-title":"Pain Physician"},{"issue":"2","key":"10.1016\/j.cll.2016.07.007_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.36076\/ppj.2010\/13\/187","article-title":"Urine drug testing in the treatment of chronic noncancer pain in a Kentucky private neuroscience practice: the potential effect of Medicare benefit changes in Kentucky","volume":"13","author":"Gilbert","year":"2010","journal-title":"Pain Physician"},{"issue":"2","key":"10.1016\/j.cll.2016.07.007_bib4","first-page":"113","article-title":"Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J\u00a0Pain"},{"issue":"3 Suppl","key":"10.1016\/j.cll.2016.07.007_bib5","first-page":"S67","article-title":"American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2\u2013guidance","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"issue":"4","key":"10.1016\/j.cll.2016.07.007_bib6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.36076\/ppj.2009\/12\/699","article-title":"Comprehensive evidence-based guidelines for interventional techniques in the management of chronic spinal pain","volume":"12","author":"Manchikanti","year":"2009","journal-title":"Pain Physician"},{"issue":"4","key":"10.1016\/j.cll.2016.07.007_bib7","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.36076\/ppj.2009\/12\/E35","article-title":"Comprehensive review of epidemiology, scope, and impact of spinal pain","volume":"12","author":"Manchikanti","year":"2009","journal-title":"Pain Physician"},{"issue":"3 Suppl","key":"10.1016\/j.cll.2016.07.007_bib8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.36076\/ppj.2012\/15\/E1","article-title":"American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part I\u2013evidence assessment","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"issue":"2","key":"10.1016\/j.cll.2016.07.007_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jat\/bkr019","article-title":"Oral fluid drug testing of chronic pain patients. II. Comparison of paired oral fluid and urine specimens","volume":"36","author":"Heltsley","year":"2012","journal-title":"J\u00a0Anal Toxicol"},{"issue":"12","key":"10.1016\/j.cll.2016.07.007_bib10","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/pme.12207","article-title":"Optimizing urine drug testing for monitoring medication compliance in pain management","volume":"14","author":"Melanson","year":"2013","journal-title":"Pain Med"},{"issue":"7","key":"10.1016\/j.cll.2016.07.007_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/j.1875-9114.2011.01089.x","article-title":"Drug testing in the workplace","volume":"32","author":"Phan","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cll.2016.07.007_bib12","unstructured":"Washington State Association of State Medical Directors. Interagency guideline on prescribing opioids for pain. 2015. p. 105."},{"key":"10.1016\/j.cll.2016.07.007_bib13","unstructured":"United States v. Zadeh. 2014, U.S. Dist. LEXIS 181500, \u00d71."},{"key":"10.1016\/j.cll.2016.07.007_bib14","unstructured":"Debbrecht-Switalski J. Evidence-based best practice for opioid prescribing and monitoring: medicolegal pain management expert symposium. International Conference on Opioids. Boston, June 6, 2016."},{"issue":"6","key":"10.1016\/j.cll.2016.07.007_bib15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med"},{"issue":"4","key":"10.1016\/j.cll.2016.07.007_bib16","first-page":"360","article-title":"Validation of the revised screener and opioid assessment for patients with pain (SOAPP-R)","volume":"9","author":"Butler","year":"2008","journal-title":"J\u00a0Pain"},{"issue":"2","key":"10.1016\/j.cll.2016.07.007_bib17","first-page":"66","article-title":"Cross-validation of a screener to predict opioid misuse in chronic pain patients (SOAPP-R)","volume":"3","author":"Butler","year":"2009","journal-title":"J\u00a0Addict Med"},{"issue":"15","key":"10.1016\/j.cll.2016.07.007_bib18","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/archinte.159.15.1681","article-title":"Hazardous and harmful alcohol consumption in primary care","volume":"159","author":"Reid","year":"1999","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.cll.2016.07.007_bib19","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jsat.2012.08.010","article-title":"Prescription opioid abuse, chronic pain, and primary care: a Co-occurring Disorders Clinic in the chronic disease model","volume":"43","author":"Pade","year":"2012","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"3","key":"10.1016\/j.cll.2016.07.007_bib20","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.addbeh.2013.11.022","article-title":"Prevalence of axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: systematic review and meta-analyses","volume":"39","author":"Goldner","year":"2014","journal-title":"Addict Behav"},{"issue":"2","key":"10.1016\/j.cll.2016.07.007_bib21","first-page":"115","article-title":"Metabolism and disposition of prescription opioids: a review","volume":"27","author":"DePriest","year":"2015","journal-title":"Forensic Sci Rev"},{"issue":"4","key":"10.1016\/j.cll.2016.07.007_bib22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/jat\/bks021","article-title":"Observations on the metabolism of morphine to hydromorphone in pain patients","volume":"36","author":"Hughes","year":"2012","journal-title":"J\u00a0Anal Toxicol"},{"issue":"2","key":"10.1016\/j.cll.2016.07.007_bib23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/jat\/bkt101","article-title":"Observations on the urine metabolic profile of codeine in pain patients","volume":"38","author":"Yee","year":"2014","journal-title":"J\u00a0Anal Toxicol"},{"issue":"7","key":"10.1016\/j.cll.2016.07.007_bib24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/jat\/bku051","article-title":"Urinary hydrocodone and metabolite distributions in pain patients","volume":"38","author":"Barakat","year":"2014","journal-title":"J\u00a0Anal Toxicol"},{"issue":"3","key":"10.1016\/j.cll.2016.07.007_bib25","first-page":"177","article-title":"Observations on hydrocodone and its metabolites in oral fluid specimens of the pain population: comparison with urine","volume":"10","author":"Cao","year":"2014","journal-title":"J\u00a0Opioid Manag"},{"issue":"7","key":"10.1016\/j.cll.2016.07.007_bib26","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/jat\/bkv050","article-title":"Prescription opioids. IV: disposition of hydrocodone in oral fluid and blood following single-dose administration","volume":"39","author":"Cone","year":"2015","journal-title":"J\u00a0Anal Toxicol"},{"issue":"8","key":"10.1016\/j.cll.2016.07.007_bib27","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/jat\/bkt066","article-title":"Prescription opioids. II. Metabolism and excretion patterns of hydrocodone in urine following controlled single-dose administration","volume":"37","author":"Cone","year":"2013","journal-title":"J\u00a0Anal Toxicol"},{"key":"10.1016\/j.cll.2016.07.007_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2015.10.049","article-title":"Opioid metabolism and clinical aspects","volume":"769","author":"Mercadante","year":"2015","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"10.1016\/j.cll.2016.07.007_bib29","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/AJP.0b013e31821d8ac1","article-title":"The metabolism of opioid agents and the clinical impact of their active metabolites","volume":"27","author":"Smith","year":"2011","journal-title":"Clin J Pain"},{"issue":"4","key":"10.1016\/j.cll.2016.07.007_bib30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0024-3205(01)01133-X","article-title":"Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide","volume":"69","author":"Wright","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.cll.2016.07.007_bib31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00007691-200404000-00020","article-title":"Detection times of drugs of abuse in blood, urine, and oral fluid","volume":"26","author":"Verstraete","year":"2004","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.cll.2016.07.007_bib32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.forsciint.2005.02.028","article-title":"Oral fluid collection: the neglected variable in oral fluid testing","volume":"150","author":"Crouch","year":"2005","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.cll.2016.07.007_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5055\/jom.2015.0252","article-title":"Specimen validity testing in urine drug monitoring of medications and illicit drugs: clinical implications","volume":"11","author":"Kirsh","year":"2015","journal-title":"J\u00a0Opioid Manag"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271216300634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271216300634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T15:26:48Z","timestamp":1657466808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271216300634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0272271216300634"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2016.07.007","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicology in Pain Management","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2016.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}